Subcutaneous administration of a neutralizing IL-1β antibody prolongs limb allograft survival.
Hautz T, Grahammer J, Moser D, Eberhart N, Zelger B, Zelger B, Blumer MJ, Drasche A, Wolfram D, Troppmair J, Öfner D, Schneeberger S.
Hautz T, et al. Among authors: zelger b.
Am J Transplant. 2018 Aug;18(8):2029-2042. doi: 10.1111/ajt.14765. Epub 2018 May 7.
Am J Transplant. 2018.
PMID: 29633557
Free PMC article.